. Author manuscript; available in PMC: 2009 Oct 14.

Published in final edited form as: Obesity (Silver Spring). 2006 Jan;14(1):36–51. doi: 10.1038/oby.2006.6

Table 2.

Absolute binding of [¹²⁵I]-iodosulpride in the striatum and midbrain regions of chronic olanzapine- and control-treated rats

	Treatment
Brain regions	Olanzapine (n = 12)	Saline (n = 12)
NAcc shell	15.00 ± 0.58	13.65 ± 0.87
NAcc core	15.90 ± 0.74	14.10 ± 0.66
VTA (r)	5.08 ± 0.26	4.87 ± 0.46
VTA (c)	7.66 ± 0.24	7.04 ± 0.26
DLS	30.77 ± 1.56^*	25.67 ± 1.26
SNpc	7.56 ± 0.35	7.72 ± 0.36

Binding is expressed in femtomoles per milligram of tissue equivalent ± SE. NAcc shell, nucleus accumbens shell region; NAcc core, nucleus accumbens core region; VTA (r), ventral tegmental area, rostral expanse; VTA (c), ventral tegmental, caudal expanse; DLS, dorsolateral striatum; SNpc, substania nigra pars compacta.

p < 0.001 significantly different from saline group.